419,930 Shares in LifeVantage Co. (NASDAQ:LFVN) Purchased by Capital Management Corp VA

Capital Management Corp VA bought a new position in shares of LifeVantage Co. (NASDAQ:LFVN) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 419,930 shares of the company’s stock, valued at approximately $5,073,000.

A number of other large investors also recently bought and sold shares of LFVN. Hillsdale Investment Management Inc. acquired a new position in shares of LifeVantage in the 1st quarter valued at about $76,000. Hantz Financial Services Inc. bought a new position in shares of LifeVantage during the second quarter valued at approximately $91,000. Ritholtz Wealth Management raised its position in shares of LifeVantage by 62.0% during the 3rd quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock worth $346,000 after purchasing an additional 10,974 shares during the period. Empowered Funds LLC lifted its holdings in shares of LifeVantage by 8.1% in the 1st quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock worth $461,000 after purchasing an additional 5,742 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its position in LifeVantage by 2.8% during the 1st quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after purchasing an additional 6,121 shares during the period. Institutional investors own 35.32% of the company’s stock.

LifeVantage Price Performance

Shares of NASDAQ LFVN opened at $13.50 on Tuesday. LifeVantage Co. has a 1-year low of $4.20 and a 1-year high of $14.71. The firm has a market capitalization of $169.09 million, a PE ratio of 42.19 and a beta of 0.84. The business’s fifty day moving average price is $11.12 and its two-hundred day moving average price is $8.50.

LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%. The firm had revenue of $47.21 million for the quarter.

LifeVantage Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be issued a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 1.19%. The ex-dividend date of this dividend is Monday, December 2nd. LifeVantage’s payout ratio is currently 50.00%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.